GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt,Andrew D Oxman,Gunn Elisabeth Vist,Regina Kunz,Yngve Falck-Ytter,Pablo Alonso-Coello,Holger J. Schünemann +6 more
Reads0
Chats0
TLDR
The advantages of the GRADE system are explored, which is increasingly being adopted by organisations worldwide and which is often praised for its high level of consistency.Abstract:
Guidelines are inconsistent in how they rate the quality of evidence and the strength of recommendations. This article explores the advantages of the GRADE system, which is increasingly being adopted by organisations worldwideread more
Citations
More filters
Journal ArticleDOI
Impact of Antibodies to Infliximab on Clinical Outcomes and Serum Infliximab Levels in Patients With Inflammatory Bowel Disease (IBD): A Meta-Analysis
TL;DR: The presence of ATIs is associated with a significantly higher risk of loss of clinical response to IFX and lower serum IFX levels in patients with IBD.
Journal ArticleDOI
Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis.
Dragan Ilic,Mia Djulbegovic,Jae Hung Jung,Eu Chang Hwang,Eu Chang Hwang,Qi Zhou,Anne Cleves,Thomas Agoritsas,Philipp Dahm +8 more
TL;DR: Clinicians and patients considering PSA based screening need to weigh these benefits against the potential short and long term harms of screening, including complications from biopsy and subsequent treatment, as well as the risk of overdiagnosis and overtreatment.
Journal ArticleDOI
Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence.
TL;DR: It seems that adding any psychosocial support to standard maintenance treatments do not add additional benefits, and data do not show differences also for contingency approaches, contrary to all expectations.
Journal ArticleDOI
The role of endoscopy in Barrett's esophagus and other premalignant conditions of the esophagus.
John A. Evans,Dayna S. Early,Norio Fukami,Tamir Ben-Menachem,Vinay Chandrasekhara,Krishnavel V. Chathadi,G. Anton Decker,Robert D. Fanelli,Deborah A. Fisher,Kimberly Foley,Joo Ha Hwang,Rajeev Jain,Terry L. Jue,Khalid Khan,Jenifer R. Lightdale,Phyllis M. Malpas,John T. Maple,Shabana F. Pasha,John R. Saltzman,Ravi Sharaf,Amandeep K. Shergill,Jason A. Dominitz,Brooks D. Cash +22 more
TL;DR: In this paper, the Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy prepared a series of statements discussing the use of GI endoscopy in common clinical situations.
Journal ArticleDOI
2020 American College of Rheumatology Guideline for the Management of Gout.
John FitzGerald,Nicola Dalbeth,Ted R. Mikuls,Romina Brignardello-Petersen,Gordon Guyatt,Aryeh M. Abeles,Allan C. Gelber,Leslie R. Harrold,Dinesh Khanna,Charles H. King,Gerald Levy,Caryn A. Libbey,David B. Mount,Michael H. Pillinger,Ann K. Rosenthal,Jasvinder A. Singh,James Edward Sims,Benjamin J Smith,Neil S. Wenger,Sangmee Sharon Bae,Abhijeet Danve,Puja P. Khanna,Seoyoung C. Kim,Aleksander Lenert,Samuel Poon,Anila Qasim,Shiv T Sehra,Tarun Sharma,Michael Toprover,Marat Turgunbaev,Linan Zeng,Mary Ann Zhang,Amy S. Turner,Tuhina Neogi +33 more
TL;DR: To provide guidance for the management of gout, including indications for and optimal use of urate‐lowering therapy (ULT), treatment of g out flares, and lifestyle and other medication recommendations.
References
More filters
Journal ArticleDOI
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
Jacques E. Rossouw,Garnet L. Anderson,Ross L. Prentice,Andrea Z. LaCroix,Charles Kooperberg,Marcia L. Stefanick,Rebecca D. Jackson,Shirley A.A. Beresford,Barbara V. Howard,Karen C. Johnson,Jane Morley Kotchen,Judith K. Ockene +11 more
TL;DR: Overall health risks exceeded benefits from use of combined estrogen plus progestin for an average 5.2-year follow-up among healthy postmenopausal US women, and the results indicate that this regimen should not be initiated or continued for primary prevention of CHD.
Journal ArticleDOI
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
Stephen B. Hulley,Deborah Grady,Trudy L. Bush,Curt D Furberg,David M. Herrington,Betty Riggs,Eric Vittinghoff +6 more
TL;DR: Treatment with oral conjugated equine estrogen plus medroxyprogesterone acetate did not reduce the overall rate of CHD events in postmenopausal women with established coronary disease and the treatment did increase the rate of thromboembolic events and gallbladder disease.
Journal ArticleDOI
Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.
Echt Ds,Philip R. Liebson,Mitchell Lb,Robert W. Peters,Obias-Manno D,Barker Ah,Arensberg D,Baker A,Lawrence S. Friedman,Greene Hl +9 more
TL;DR: There was an excess of deathsDue to arrhythmia and deaths due to shock after acute recurrent myocardial infarction in patients treated with encainide or flecainide.
Journal ArticleDOI
A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction.
TL;DR: Finding and analyzing all therapeutic trials in a given field has become such a difficult and specialized task that the clinical experts called on to summarize the evidence in a timely fashion need access to better databases and new statistical techniques to assist them.
Journal ArticleDOI
Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group.
David Atkins,Martin P Eccles,Signe Flottorp,Gordon H. Guyatt,David Henry,Suzanne Hill,Alessandro Liberati,Dianne L. O'Connell,Andrew D Oxman,Bob Phillips,Holger J. Schünemann,Holger J. Schünemann,Tessa Tan-Torres Edejer,Gunn Elisabeth Vist,John W Williams +14 more
TL;DR: The objective was to critically appraise six prominent systems for grading levels of evidence and the strength of recommendations as a basis for agreeing on characteristics of a common, sensible approach.